Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rheumatoid arthritis: 2014 treat-to-target RA recommendations--strategy is key.

Literature DB >> 26195337

Rheumatoid arthritis: 2014 treat-to-target RA recommendations--strategy is key.

Abstract

The treatment recommendations for rheumatoid arthritis (RA) have been updated. Among the changes included, rheumatologists are advised to share treatment decision-making with patients and to maximize patients' quality of life by aiming for clinical remission. The update is based on scientific evidence, but more research is needed to strengthen RA treatment strategies.

Entities: Disease Species

Mesh：

Substances：
Antirheumatic Agents

Year: 2015 PMID： 26195337 DOI： 10.1038/nrrheum.2015.98

Source DB: PubMed Journal: Nat Rev Rheumatol ISSN： 1759-4790 Impact factor: 20.543

9 in total

Review 1. High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis.

Authors: Christophe Meune; Emmanuel Touzé; Ludovic Trinquart; Yannick Allanore
Journal: Arch Cardiovasc Dis Date: 2010-05-18 Impact factor: 2.340

Review 2. Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.

Authors: R Knevel; M Schoels; T W J Huizinga; D Aletaha; G R Burmester; B Combe; R B Landewé; J S Smolen; T Sokka; D M F M van der Heijde
Journal: Ann Rheum Dis Date: 2010-05-06 Impact factor: 19.103

3. American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.

Authors: David T Felson; Josef S Smolen; George Wells; Bin Zhang; Lilian H D van Tuyl; Julia Funovits; Daniel Aletaha; Cornelia F Allaart; Joan Bathon; Stefano Bombardieri; Peter Brooks; Andrew Brown; Marco Matucci-Cerinic; Hyon Choi; Bernard Combe; Maarten de Wit; Maxime Dougados; Paul Emery; Daniel Furst; Juan Gomez-Reino; Gillian Hawker; Edward Keystone; Dinesh Khanna; John Kirwan; Tore K Kvien; Robert Landewé; Joachim Listing; Kaleb Michaud; Emilio Martin-Mola; Pamela Montie; Theodore Pincus; Pamela Richards; Jeffrey N Siegel; Lee S Simon; Tuulikki Sokka; Vibeke Strand; Peter Tugwell; Alan Tyndall; Desirée van der Heijde; Suzan Verstappen; Barbara White; Frederick Wolfe; Angela Zink; Maarten Boers
Journal: Ann Rheum Dis Date: 2011-03 Impact factor: 19.103

4. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis.

Authors: Y P M Goekoop-Ruiterman; J K de Vries-Bouwstra; P J S M Kerstens; M M J Nielen; K Vos; D van Schaardenburg; I Speyer; P E H Seys; F C Breedveld; C F Allaart; B A C Dijkmans
Journal: Ann Rheum Dis Date: 2010-01 Impact factor: 19.103

Review 5. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search.

Authors: Monika Schoels; Rachel Knevel; Daniel Aletaha; Johannes W J Bijlsma; Ferdinand C Breedveld; Dimitrios T Boumpas; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Maxime Dougados; Paul Emery; Desirée van der Heijde; Tom W J Huizinga; Joachim Kalden; Edward C Keystone; Tore K Kvien; Emilio Martin-Mola; Carlomaurizio Montecucco; Maarten de Wit; Josef S Smolen
Journal: Ann Rheum Dis Date: 2010-04 Impact factor: 19.103

6. Treating rheumatoid arthritis to target: recommendations of an international task force.

Authors: Josef S Smolen; Daniel Aletaha; Johannes W J Bijlsma; Ferdinand C Breedveld; Dimitrios Boumpas; Gerd Burmester; Bernard Combe; Maurizio Cutolo; Maarten de Wit; Maxime Dougados; Paul Emery; Alan Gibofsky; Juan Jesus Gomez-Reino; Boulos Haraoui; Joachim Kalden; Edward C Keystone; Tore K Kvien; Iain McInnes; Emilio Martin-Mola; Carlomaurizio Montecucco; Monika Schoels; Désirée van der Heijde; Desirée van der Heijde
Journal: Ann Rheum Dis Date: 2010-03-09 Impact factor: 19.103

7. Aggressive therapy in patients with early arthritis results in similar outcome compared with conventional care: the STREAM randomized trial.

Authors: Izhar C van Eijk; Markus M J Nielen; Irene van der Horst-Bruinsma; Gerard J Tijhuis; Maarten Boers; Ben A C Dijkmans; Dirkjan van Schaardenburg
Journal: Rheumatology (Oxford) Date: 2011-12-13 Impact factor: 7.580

Review 8. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update.

Authors: Michaela A Stoffer; Monika M Schoels; Josef S Smolen; Daniel Aletaha; Ferdinand C Breedveld; Gerd Burmester; Vivian Bykerk; Maxime Dougados; Paul Emery; Boulos Haraoui; Juan Gomez-Reino; Tore K Kvien; Peter Nash; Victoria Navarro-Compán; Marieke Scholte-Voshaar; Ronald van Vollenhoven; Désirée van der Heijde; Tanja A Stamm
Journal: Ann Rheum Dis Date: 2015-05-19 Impact factor: 19.103

Review 9. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.

Authors: Josef S Smolen; Ferdinand C Breedveld; Gerd R Burmester; Vivian Bykerk; Maxime Dougados; Paul Emery; Tore K Kvien; M Victoria Navarro-Compán; Susan Oliver; Monika Schoels; Marieke Scholte-Voshaar; Tanja Stamm; Michaela Stoffer; Tsutomu Takeuchi; Daniel Aletaha; Jose Louis Andreu; Martin Aringer; Martin Bergman; Neil Betteridge; Hans Bijlsma; Harald Burkhardt; Mario Cardiel; Bernard Combe; Patrick Durez; Joao Eurico Fonseca; Alan Gibofsky; Juan J Gomez-Reino; Winfried Graninger; Pekka Hannonen; Boulos Haraoui; Marios Kouloumas; Robert Landewe; Emilio Martin-Mola; Peter Nash; Mikkel Ostergaard; Andrew Östör; Pam Richards; Tuulikki Sokka-Isler; Carter Thorne; Athanasios G Tzioufas; Ronald van Vollenhoven; Martinus de Wit; Desirée van der Heijde
Journal: Ann Rheum Dis Date: 2015-05-12 Impact factor: 19.103

9 in total

5 in total

1. Improving Quality of Care in Rheumatoid Arthritis Through Mobile Patient-Reported Outcome Measurement: Focus Group Study.

Authors: Sonali Desai; Emma Stevens; Srinivas Emani; Peter Meyers; Maura Iversen; Daniel H Solomon
Journal: JMIR Form Res Date: 2020-05-27

5. Ultrasound is more reliable than inflammatory parameters to evaluate disease activity in patients with RA receiving tocilizumab therapy.

Authors: Wen-Chan Chiu; Han-Ming Lai; Chi-Hua Ko; Jia-Feng Chen; Chung-Yuan Hsu; Ying-Chou Chen
Journal: J Investig Med Date: 2018-03-25 Impact factor: 2.895